Rudrani Maity, Vellupillai Mariappan Raja Sankari, Umapathy Snekhalatha, Shubashini Velu, Tahani Jaser Alahmadi, Zaid Ali Alhababi, Hend Khalid Alkahtani
{"title":"Early detection of Alzheimer's disease in structural and functional MRI.","authors":"Rudrani Maity, Vellupillai Mariappan Raja Sankari, Umapathy Snekhalatha, Shubashini Velu, Tahani Jaser Alahmadi, Zaid Ali Alhababi, Hend Khalid Alkahtani","doi":"10.3389/fmed.2024.1520878","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To implement state-of-the-art deep learning architectures such as Deep-Residual-U-Net and DeepLabV3+ for precise segmentation of hippocampus and ventricles, in functional magnetic resonance imaging (fMRI). Integrate VGG-16 with Random Forest (VGG-16-RF) and VGG-16 with Support Vector Machine (VGG-16-SVM) to enhance the binary classification accuracy of Alzheimer's disease, comparing their performance against traditional classifiers.</p><p><strong>Method: </strong>OpenNeuro and Harvard's Data verse provides Alzheimer's coronal functional MRI data. Ventricles and hippocampus are segmented using a Deep-Residual-UNet and Deep labV3+ system. The functional features were extracted from each segmented component and classified using SVM, Adaboost, Logistic regression, and VGG 16, DenseNet-169, VGG-16-RF, and VGG-16-SVM classifier.</p><p><strong>Results: </strong>This research proposes a precise and efficient deep-learning architecture like DeepLab V3+ and Deep Residual U-NET for hippocampus and ventricle segmentation in detection of AD. DeepLab V3+ has produced a good segmentation accuracy of 94.62% with Jaccard co-efficient of 85.5% and dice co-efficient of 84.75%. Among the three ML classifiers used, SVM has provided a good accuracy of 93%. Among some DL techniques, VGG-16-RF classifier has given better accuracy of 96.87%.</p><p><strong>Conclusion: </strong>The novelty of this work lies in the seamless integration of advanced segmentation techniques with hybrid classifiers, offering a robust and scalable framework for early AD detection. The proposed study demonstrates a significant advancement in the early detection of Alzheimer's disease by integrating state-of-the-art deep learning models and comprehensive functional connectivity analysis. This early detection capability is crucial for timely intervention and better management of the disease in neurodegenerative disorder diagnostics.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"11 ","pages":"1520878"},"PeriodicalIF":3.1000,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669652/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2024.1520878","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To implement state-of-the-art deep learning architectures such as Deep-Residual-U-Net and DeepLabV3+ for precise segmentation of hippocampus and ventricles, in functional magnetic resonance imaging (fMRI). Integrate VGG-16 with Random Forest (VGG-16-RF) and VGG-16 with Support Vector Machine (VGG-16-SVM) to enhance the binary classification accuracy of Alzheimer's disease, comparing their performance against traditional classifiers.
Method: OpenNeuro and Harvard's Data verse provides Alzheimer's coronal functional MRI data. Ventricles and hippocampus are segmented using a Deep-Residual-UNet and Deep labV3+ system. The functional features were extracted from each segmented component and classified using SVM, Adaboost, Logistic regression, and VGG 16, DenseNet-169, VGG-16-RF, and VGG-16-SVM classifier.
Results: This research proposes a precise and efficient deep-learning architecture like DeepLab V3+ and Deep Residual U-NET for hippocampus and ventricle segmentation in detection of AD. DeepLab V3+ has produced a good segmentation accuracy of 94.62% with Jaccard co-efficient of 85.5% and dice co-efficient of 84.75%. Among the three ML classifiers used, SVM has provided a good accuracy of 93%. Among some DL techniques, VGG-16-RF classifier has given better accuracy of 96.87%.
Conclusion: The novelty of this work lies in the seamless integration of advanced segmentation techniques with hybrid classifiers, offering a robust and scalable framework for early AD detection. The proposed study demonstrates a significant advancement in the early detection of Alzheimer's disease by integrating state-of-the-art deep learning models and comprehensive functional connectivity analysis. This early detection capability is crucial for timely intervention and better management of the disease in neurodegenerative disorder diagnostics.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world